The bleeding time test measures how long bleeding lasts after a standardized small skin incision to evaluate platelet function and primary hemostasis. It helps detect platelet disorders, von Willebrand disease, or effects of antiplatelet medications, and guides further clotting investigations. Because of variability and invasiveness, it is now less commonly used, with more precise platelet function tests available.

Bleeding time can be measured clinically (Ivy method): place a BP cuff at 40 mmHg on the upper arm, make a standardized 5–10 mm forearm incision, blot blood every 30 seconds without touching the wound edge, and record time until bleeding stops. Because results vary, modern practice favors platelet count, PT/INR, aPTT or platelet-function tests. Testing should be done by trained staff.

BT, CT, PT and aPTT are basic haemostasis tests. Bleeding time (BT) assesses platelet function and primary haemostasis. Clotting time (CT) measures how long blood takes to clot in vitro. Prothrombin time (PT) evaluates the extrinsic and common coagulation pathways and monitors vitamin K antagonist therapy. Activated partial thromboplastin time (aPTT) assesses intrinsic/common pathways and monitors heparin therapy.

Do you mean menstrual bleeding, donating blood, or bleeding during a medical test/procedure? Please clarify which you mean so I can give a 50–75 word answer based on trusted guidance.

Normal menstrual bleeding lasts about 3 to 7 days, with typical blood loss around 30 to 40 mL (up to about 80 mL). Flow is usually light to moderate, varying day to day; color can range from bright red to brown. Small clots under 2 to 3 cm are common. Very heavy bleeding—soaking a pad or tampon hourly, large clots, or prolonged bleeding—needs medical evaluation.

Diagnosing a platelet disorder begins with a detailed bleeding history and physical exam, plus a complete blood count with platelet count and peripheral smear. Further testing may include platelet function studies (aggregation/adhesion tests), von Willebrand factor assays, coagulation screens (PT/aPTT), and specialized tests (flow cytometry, platelet secretion assays). Bone marrow biopsy or genetic testing are used when inherited or marrow causes are suspected.